Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Cancer Medicine|July 30, 2021
Inflammatory breast cancer appearance at presentation is associated with overall survivalWintana Balema, Diane Liu, Yu Shen, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Soluble E-cadherin Drives Brain Metastasis in Inflammatory Breast CancerXiaoding Hu, Yun Xiong, Emilly S Villodre, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Serum S100A8/S100A9 is associated with increased risk of brain metastasis in patients with inflammatory breast cancerEmilly S Villodre, Juhee Song, Xiaoding Hu, et al.
Life Science Alliance|February 5, 2024
Genome-wide CRISPR screen reveals the synthetic lethality between BCL2L1 inhibition and radiotherapyLing Yin, Xiaoding Hu, Guangsheng Pei, et al.
Communications Biology|January 16, 2021
Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancerXiaoding Hu, Emilly S Villodre, Richard Larson, et al.
Breast Cancer Research : BCR|April 19, 2015
Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical modelLara Lacerda, Bisrat G Debeb, Daniel Smith, et al.
Stem Cells (Dayton, Ohio)|September 11, 2012
Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signalingBisrat G Debeb, Lara Lacerda, Wei Xu, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2015
High-density and very-low-density lipoprotein have opposing roles in regulating tumor-initiating cells and sensitivity to radiation in inflammatory breast cancerAdam R Wolfe, Rachel L Atkinson, Jay P Reddy, et al.
Stem Cells Translational Medicine|May 17, 2014
Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiationLara Lacerda, Jay P Reddy, Diane Liu, et al.
Neuro-Oncology|January 23, 2026
Soluble E-cadherin-CXCL1-CXCR2 Axis as a Therapeutic Vulnerability in Inflammatory Breast Cancer Brain MetastasisXiaoding Hu, Yun Xiong, Emilly S Villodre, et al.
Pageof 6